Jason M. Pogue, PharmD

home / authors / jason-m-pogue-pharmd

Pogue is a clinical professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy in Ann Arbor and an infectious diseases clinical pharmacist at Michigan Medicine.

Articles

Sulbactam for Treatment of Carbapenem-Resistant Acinetobacter baumannii

Sulbactam for Treatment of Carbapenem-Resistant Acinetobacter baumannii

Walaiporn Wangchinda, MD;Jason M. Pogue, PharmD
August 24th 2023

This is a challenging pathogen, requiring pharmacokinetic and pharmacodynamic considerations; the recent FDA approval of sulbactam-durlobactam offers new hope.

Read More

Site Logo

Antibiograms for Optimizing Empiric Therapy: Use Them Wisely

Jason M. Pogue, PharmD
August 21st 2018

An understanding of the limitations in their functionality and strategies for more appropriate applications are necessary for clinicians.

Read More

Latest Updated Articles

The Evolution of Lenacapavir in HIV Treatment
Published: July 24th 2024 | Updated: July 25th 2024
The Evolution of Lenacapavir in HIV Treatment
Contagion Summer 2024 Digital Edition
Published: July 22nd 2024 | Updated: July 27th 2024
Contagion Summer 2024 Digital Edition
Dovato Shown to be as Effective as Biktarvy for HIV Maintenance Therapy
Published: July 23rd 2024 | Updated: July 27th 2024
Dovato Shown to be as Effective as Biktarvy for HIV Maintenance Therapy
Efficacy of the Antibiotic Omadacycline in Treating Pneumonia
Published: July 22nd 2024 | Updated: July 22nd 2024
Efficacy of the Antibiotic Omadacycline in Treating Pneumonia
High Rates of HCV Reinfection in NYC
Published: July 23rd 2024 | Updated: July 27th 2024
High Rates of HCV Reinfection in NYC
FDA and European Commission Approve Therapy for Multidrug Resistant Tuberculosis
Published: July 3rd 2024 | Updated: July 27th 2024
FDA and European Commission Approve Therapy for Multidrug Resistant Tuberculosis
© 2024 MJH Life Sciences

All rights reserved.